Psychiatry and Neurology, Neurology · Atlanta, GA
NPI
1295709772
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
6
Medicare group memberships
Hospitals
3
Hospital affiliations
3200 Downwood Cir NW Ste 550
Atlanta, GA, 30327
Phone (404) 351-0205
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
1,870 services
Medicare patients, 2024
328
Average age 72
Drug cost, 2024
$1.6M
3,100 prescriptions
Company payments, 2025
$36K
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lawrence G Seiden was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 427 times for 265 patients. In total Lawrence G Seiden billed 1,870 services in 27 codes, and Medicare paid $88K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-24.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 427 | 265 | $11.23 | $4,796 |
| 99214 Office E&M - Established | Office | 249 | 177 | $82.85 | $21K |
| 99215 Office E&M - Established | Office | 135 | 91 | $108.73 | $15K |
| 99205 Office E&M - New | Office | 51 | 51 | $159.10 | $8,114 |
| 95819 Neurologic | Office | 51 | 51 | $316.23 | $16K |
| 99213 Office E&M - Established | Office | 26 | 26 | $55.42 | $1,441 |
| 99204 Office E&M - New | Office | 25 | 25 | $119.30 | $2,983 |
| 95724 Neurologic | Office | 25 | 25 | $234.33 | $5,858 |
| 70551 MRI/MRA - Head and Neck | Office | 13 | 13 | $145.94 | $1,897 |
| 95816 Neurologic | Office | 11 | 11 | $40.19 | $442 |
By year: 2022 $84K for 2,444 services; 2023 $77K for 1,384 services; 2024 $88K for 1,870 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lawrence G Seiden prescribed most often to Medicare patients was Levetiracetam, with 391 prescriptions and refills. In total Lawrence G Seiden wrote 3,100 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 391 | 878 | 102 | $23K |
| Xcopri Cenobamate | 285 | 310 | 29 | $503K |
| Lamotrigine Generic | 262 | 622 | 66 | $6,836 |
| Lacosamide Generic | 177 | 323 | 34 | $33K |
| Donepezil Hcl Generic | 120 | 246 | 37 | $1,257 |
| Memantine Hcl Generic | 115 | 281 | 39 | $4,482 |
| Gabapentin Generic | 110 | 244 | 35 | $2,274 |
| Oxcarbazepine Generic | 97 | 187 | 25 | $7,001 |
| Clobazam Generic | 73 | 104 | 15 | $12K |
| Topiramate Generic | 62 | 136 | 16 | $882 |
| Escitalopram Oxalate Generic | 58 | 100 | 13 | $558 |
| Zonisamide Generic | 53 | 95 | Under 11 | $2,908 |
| Briviact Brivaracetam | 51 | 60 | Under 11 | $88K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 45 | 93 | Under 11 | $1,556 |
| Vimpat Lacosamide | 45 | 53 | Under 11 | $51K |
Brand drugs: - claims; generic drugs: 2,475 claims; opioid claims: 64.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lawrence G Seiden $36K ($36K in general payments such as food, travel and fees) from 35 companies. The largest payer was SK Life Science, Inc. with $20K.
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 26 | $20K |
| Jazz Pharmaceuticals Inc. JAZZ | 17 | $13K |
| UCB, Inc. UCB.BR | 32 | $1,020 |
| Abbvie Inc. ABBV | 13 | $286 |
| EMD Serono, Inc. MRK.DE | 7 | $169 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $138 |
| Lundbeck LLC | 4 | $124 |
| Biogen, Inc. BIIB | 3 | $88.13 |
| Genzyme Corporation SNY | 3 | $87.3 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $87.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.